Xtant Medical Holdings, Inc. cotiza a 0.33 USD y tiene una capitalización bursátil de $46M. En los últimos 12 meses ha facturado $110M con un margen de flujo de caja libre del 7.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.02 | $-0.01 |
| Estimado | $-0.02 | $-0.02 | $-0.02 | — |
| Sorpresa | — | — | +0.0% | — |
| Métrica | XTNT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 62.9% | 57.0% | +5.9% |
| Operating Margin | 5.4% | -38.6% | +44.1% |
| Net Margin | 3.7% | -33.6% | +37.3% |
| FCF Margin | 7.6% | -13.9% | +21.4% |
| ROE | 9.8% | -40.4% | +50.2% |
| ROA | 5.3% | -32.0% | +37.3% |
| Current Ratio | 2.65 | 2.84 | -0.19 |
| Debt / Equity | 0.22 | 0.28 | -0.06 |